Publicaciones en colaboración con investigadores/as de Charles University in Prague (1)

2017

  1. Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis

    Multiple Sclerosis, Vol. 23, Núm. 10, pp. 1367-1376